(Answered) NR601 Week 1: Discussion Board – Polypharmacy

The purpose of student discussions is to provide the opportunity for deeper understanding of polypharmacy  

 Activity Learning Outcomes 

Through this discussion, the student will demonstrate the ability to: 

  1. Summarize the different polypharmacy definitions found within the literature. (WO1.5) (CO1) 
  2. Discuss polypharmacy risk factors (WO1.5) (CO1)  
  3. Explain thee actions steps for polypharmacy prevention (WO1.5) (CO1, 7)   

 Due Date:  

The initial posting to the graded collaborative discussions is due by Wednesday, 11:59 p.m. MT.  

Peer responses and responses to faculty must be posted prior to the week deadline of Sunday 11:59 MT.  

A 10% late penalty will be imposed for discussions posted after the deadline on Wednesday, regardless of the number of days late. NOTHING will be accepted after 11:59pm MT on Sunday (i.e. student will receive an automatic 0).  

Total Points Possible: 

50 points

Requirements: 

Your initial discussion post should include the following: 

  1. Identify and discuss 2-3 definitions of polypharmacy (there are multiple definitions). Your textbook can count as 1 reference. You must also include an additional reference from an evidence–based practice journal article or national guideline. 
  2. Identify three risk factors that can lead to polypharmacy. Explain the rationale for why each listed item is a risk factor. Risk factors are different than adverse drug reactions. ADRs can be a result of polypharmacy, and is important, but ADRs are not a risk factor. 
  3. Explore three action steps that a provider can take to prevent polypharmacy. 
  4. Provide an example of how your clinical preceptors have addressed polypharmacy. 

 

DISCUSSION CONTENT 
Category  Points  %  Description 
Application of Course Knowledge   15  30  1.  Includes more than one definition of polypharmacy  

2. Includes three risk factors that can lead to polypharmacy with rationale.  

3. Includes three action steps that a provider can take to prevent polypharmacy. 

4. Provides an example of how the clinical preceptor has addressed polypharmacy. 
Support from Evidence-Based Practice (EBP)  10  20 
  1. Discussion post is supported with appropriate, scholarly sources; AND  
  2. Sources are published within the last 5 years ; AND
  3. Reference list is provided and in-text citations match; AND 
  4. Includes a minimum of one scholarly reference in addition to the textbook 

 
Interactive Dialogue  15  30 
  1. Student provides a substantive* response to at least one topic-related post of a peer; AND 
  2. Student provides a substantive response to any faculty questions asked regarding the initial student post.  
  3. Evidence from appropriate scholarly sources are included;
  4. Submits a minimum of two posts on two different days. 

 

(*) A substantive post adds new content or insights to the discussion thread and information from student’s original post is not reused in peer or faculty response 
  40  80%  Total CONTENT Points= 40 pts 
DISCUSSION FORMAT 
Category  Points  %  Description 
Organization  5  10 
  1. Discussion is presented in a logical format, AND 
  2. Responses are in sequence with the listed bullet points AND 
  3. The discussion response is understandable and easy to follow AND 
  4. All responses are relevant to the discussion  topic. 

 
Grammar, Syntax, Spelling & Punctuation  5  10  Discussion post has minimal grammar, syntax, spelling, punctuation, or APA format errors* 

 
  10  20%  Total FORMAT Points= 10 pts 
  50  100% 

Answer:

Week 1: Discussion Board – Polypharmacy

Polypharmacy has numerous definitions; it’s a phrase used for describing if an individual takes way too many medications for starters given disease procedure. Based on Mortazavi et al., 2016 polypharmacy describes issues related to many drug ingestion and start using. You will find numerous signifying for polypharmacy including unneeded drug use and utilizing medicines with no indication or explanation (Mortazavi et al., 2016).

For individuals that take several drugs it’s crucial for the provider to inform on the risk factors which can result in polypharmacy. A risk factor which is related with polypharmacy is individuals who self medicate. The issue with self medication…Please click the icon below to purchase the full answer at only $5.